Free Trial

Alcon (ALC) Stock Forecast & Price Target

Alcon logo
$85.13 -0.04 (-0.05%)
(As of 11/15/2024 ET)

Alcon - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
13

Based on 15 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 2 have given a hold rating, and 13 have given a buy rating for ALC.

Consensus Price Target

$101.51
19.24% Upside
According to the 15 analysts' twelve-month price targets for Alcon, the average price target is $101.51. The highest price target for ALC is $110.00, while the lowest price target for ALC is $85.00. The average price target represents a forecasted upside of 19.24% from the current price of $85.13.
Get the Latest News and Ratings for ALC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alcon and its competitors.

Sign Up

ALC Analyst Ratings Over Time

TypeCurrent Forecast
11/18/23 to 11/17/24
1 Month Ago
10/19/23 to 10/18/24
3 Months Ago
8/20/23 to 8/19/24
1 Year Ago
11/18/22 to 11/18/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
7 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$101.51$101.05$97.28$93.19
Forecasted Upside19.24% Upside6.17% Upside1.06% Upside32.07% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alcon Stock vs. The Competition

TypeAlconMedical CompaniesS&P 500
Consensus Rating Score
2.87
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside19.24% Upside28,534.46% Upside9.87% Upside
News Sentiment Rating
Positive News

See Recent ALC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/12/2024Needham & Company LLC
3 of 5 stars
 Reiterated RatingBuy ➝ Buy$107.00 ➝ $107.00+23.64%
10/15/2024KeyCorp
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$103.00 ➝ $107.00+10.08%
10/14/2024BTIG Research
2 of 5 stars
 Boost TargetBuy ➝ Buy$104.00 ➝ $106.00+9.40%
10/10/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
I. Kirby
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
9/10/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Reynolds-Clar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform
8/22/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$94.00 ➝ $105.00+9.88%
8/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$103.00 ➝ $110.00+16.25%
8/22/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$104.00 ➝ $110.00+16.25%
7/15/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$65.00 ➝ $85.00-7.35%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$95.00 ➝ $100.00+12.02%
5/15/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $105.00+17.62%
4/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.95%
3/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$90.00 ➝ $100.00+16.31%
2/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $96.60+13.10%
11/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$94.00 ➝ $88.00+23.40%
8/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$79.80 ➝ $89.30+11.29%
3/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
11/21/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetCHF 84 ➝ CHF 80
11/17/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$67.00 ➝ $69.00+4.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:43 AM ET.


Should I Buy Alcon Stock? ALC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 31, 2024. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

Alcon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Alcon Inc.:

  • Alcon Inc. has shown a positive Fifty-Two Week Performance of 11.11%.
  • Recent data indicates a Month-to-Month Change Percentage of 9.59%, suggesting potential growth.
  • With a low Short Percentage of Float at 0.87%, there is less short interest in the company.
  • Alcon Inc.'s Average Daily Volume is 815,800, indicating active trading in the stock.
  • The current Price on Record Date is $78.12, providing a snapshot of the stock's value.

Alcon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Alcon Inc. for these reasons:

  • The Institutional Ownership Percentage is 60.3%, which may lead to less volatility but also less potential for rapid price movements.
  • The Days to Cover ratio is 5.2, indicating a longer time for short sellers to cover their positions.
  • There has been a decrease in Shares Shorted from the previous month, which could indicate a lack of confidence in the stock.
  • Alcon Inc. has no Institutional Ownership Percentage, potentially signaling lower institutional support.
  • The Stock has a Short Percentage of Float at 0.87%, which may indicate some bearish sentiment in the market.

ALC Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $101.51, with a high forecast of $110.00 and a low forecast of $85.00.

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALC shares.

According to analysts, Alcon's stock has a predicted upside of 19.24% based on their 12-month stock forecasts.

Over the previous 90 days, Alcon's stock had 2 upgrades by analysts.

Alcon has been rated by research analysts at BTIG Research, KeyCorp, Needham & Company LLC, Oppenheimer, Redburn Atlantic, Robert W. Baird, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Analysts like Alcon more than other "medical" companies. The consensus rating score for Alcon is 2.87 while the average consensus rating score for "medical" companies is 2.80. Learn more on how ALC compares to other companies.


This page (NYSE:ALC) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners